Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Harmony Biosciences Holdings (HRMY) EPS (Basic): 2019-2024

Historic EPS (Basic) for Harmony Biosciences Holdings (HRMY) over the last 6 years, with Dec 2024 value amounting to $2.56.

  • Harmony Biosciences Holdings' EPS (Basic) rose 8.64% to $0.88 in Q3 2025 from the same period last year, while for Sep 2025 it was $3.23, marking a year-over-year increase of 50.23%. This contributed to the annual value of $2.56 for FY2024, which is 17.97% up from last year.
  • Per Harmony Biosciences Holdings' latest filing, its EPS (Basic) stood at $2.56 for FY2024, which was up 17.97% from $2.17 recorded in FY2023.
  • Harmony Biosciences Holdings' EPS (Basic)'s 5-year high stood at $3.07 during FY2022, with a 5-year trough of -$2.48 in FY2020.
  • In the last 3 years, Harmony Biosciences Holdings' EPS (Basic) had a median value of $2.56 in 2024 and averaged $2.60.
  • As far as peak fluctuations go, Harmony Biosciences Holdings' EPS (Basic) soared by 411.67% in 2022, and later decreased by 29.32% in 2023.
  • Over the past 5 years, Harmony Biosciences Holdings' EPS (Basic) (Yearly) stood at -$2.48 in 2020, then spiked by 124.19% to $0.60 in 2021, then spiked by 411.67% to $3.07 in 2022, then fell by 29.32% to $2.17 in 2023, then rose by 17.97% to $2.56 in 2024.